APP and Alzheimer disease: Of possibly greater value would be the use of human in vitro models of induced pluripotent stem cell (iPSC)-derived control, AD and AD-DS neurons to determine whether or not KLC1 is reduced and, if so, the potential consequences for the transport of known cargoes, such as APP.